<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" VersionID="2" Owner="NLM" IndexingMethod="Automated"><PMID Version="2">37158835</PMID><DateCompleted><Year>2023</Year><Month>05</Month><Day>11</Day></DateCompleted><DateRevised><Year>2023</Year><Month>06</Month><Day>15</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1471-2334</ISSN><JournalIssue CitedMedium="Internet"><Volume>23</Volume><Issue>1</Issue><PubDate><Year>2023</Year><Month>May</Month><Day>08</Day></PubDate></JournalIssue><Title>BMC infectious diseases</Title><ISOAbbreviation>BMC Infect Dis</ISOAbbreviation></Journal><ArticleTitle>Comparing the performance of dengue virus IgG and IgG-capture enzyme-linked immunosorbent assays in seroprevalence study.</ArticleTitle><Pagination><StartPage>301</StartPage><MedlinePgn>301</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">301</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1186/s12879-023-08307-8</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Dengue virus (DENV) is the leading cause of arboviral diseases in humans worldwide. Currently Dengvaxia, the first dengue vaccine licensed in 20 countries, was recommended for DENV seropositive individuals aged 9-45 years. Studying dengue seroprevalence can improve our understanding of the epidemiology and transmission dynamics of DENV, and facilitate future intervention strategies and assessment of vaccine efficacy. Several DENV envelope protein-based serological tests including IgG and IgG-capture enzyme-linked immunosorbent assays (ELISAs) have been employed in seroprevalence studies. Previously DENV IgG-capture ELISA was reported to distinguish primary and secondary DENV infections during early convalescence, however, its performance over time and in seroprevalence study remains understudied.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">In this study, we used well-documented neutralization test- or reverse-transcription-polymerase-chain reaction-confirmed serum/plasma samples including DENV-na&#xef;ve, primary and secondary DENV, primary West Nile virus, primary Zika virus, and Zika with previous DENV infection panels to compare the performance of three ELISAs.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">The sensitivity of the InBios IgG ELISA was higher than that of InBios IgG-capture and SD IgG-capture ELISAs. The sensitivity of IgG-capture ELISAs was higher for secondary than primary DENV infection panel. Within the secondary DENV infection panel, the sensitivity of InBios IgG-capture ELISA decreased from 77.8% at &lt;&#x2009;6 months to 41.7% at 1-1.5 years, 28.6% at 2-15 years and 0% at &gt;&#x2009;20 years (p&#x2009;&lt;&#x2009;0.001, Cochran-Armitage test for trend), whereas that of IgG ELISA remains 100%. A similar trend was observed for SD IgG-capture ELISA.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Our findings demonstrate higher sensitivity of DENV IgG ELISA than IgG-capture ELISA in seroprevalence study and interpretation of DENV IgG-capture ELISA should take sampling time and primary or secondary DENV infection into consideration.</AbstractText><CopyrightInformation>&#xa9; 2023. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Tsai</LastName><ForeName>Jih-Jin</ForeName><Initials>JJ</Initials><AffiliationInfo><Affiliation>Tropical Medicine Center, Kaohsiung Medical University Hospital, Kaohsiung, Taiwan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Division of Infectious Diseases, Department of Internal Medicine, Kaohsiung Medical University Hospital, Kaohsiung, Taiwan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>School of Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tsai</LastName><ForeName>Ching-Yi</ForeName><Initials>CY</Initials><AffiliationInfo><Affiliation>Tropical Medicine Center, Kaohsiung Medical University Hospital, Kaohsiung, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lin</LastName><ForeName>Ping-Chang</ForeName><Initials>PC</Initials><AffiliationInfo><Affiliation>Tropical Medicine Center, Kaohsiung Medical University Hospital, Kaohsiung, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Chun-Hong</ForeName><Initials>CH</Initials><AffiliationInfo><Affiliation>National Mosquito-Borne Diseases Control Research Center, Zhunan, Taiwan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>National Institute of Infectious Diseases and Vaccinology, National Health Research Institutes, Zhunan, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tsai</LastName><ForeName>Wen-Yang</ForeName><Initials>WY</Initials><AffiliationInfo><Affiliation>Department of Tropical Medicine, Medical Microbiology and Pharmacology, John A. Burns School of Medicine, University of Hawaii at Manoa, Honolulu, HI, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dai</LastName><ForeName>Yu-Ching</ForeName><Initials>YC</Initials><AffiliationInfo><Affiliation>Department of Tropical Medicine, Medical Microbiology and Pharmacology, John A. Burns School of Medicine, University of Hawaii at Manoa, Honolulu, HI, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lin</LastName><ForeName>Yen-Chia</ForeName><Initials>YC</Initials><AffiliationInfo><Affiliation>Department of Tropical Medicine, Medical Microbiology and Pharmacology, John A. Burns School of Medicine, University of Hawaii at Manoa, Honolulu, HI, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pedroso</LastName><ForeName>Celia</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>LAPI-Laborat&#xf3;rio de Pesquisa em Infectologia-School of Medicine, Federal University of Bahia, Salvador, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Brites</LastName><ForeName>Carlos</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>LAPI-Laborat&#xf3;rio de Pesquisa em Infectologia-School of Medicine, Federal University of Bahia, Salvador, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Wei-Kung</ForeName><Initials>WK</Initials><AffiliationInfo><Affiliation>Department of Tropical Medicine, Medical Microbiology and Pharmacology, John A. Burns School of Medicine, University of Hawaii at Manoa, Honolulu, HI, USA. wangwk@hawaii.edu.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>P30 GM114737</GrantID><Acronym>GM</Acronym><Agency>NIGMS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 AI149502</GrantID><Acronym>AI</Acronym><Agency>NIAID NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>P30GM114737</GrantID><Acronym>GM</Acronym><Agency>NIGMS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>1R01AI149502-01</GrantID><Acronym>AI</Acronym><Agency>NIAID NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>05</Month><Day>08</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>BMC Infect Dis</MedlineTA><NlmUniqueID>100968551</NlmUniqueID><ISSNLinking>1471-2334</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D007074">Immunoglobulin G</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="ErratumIn"><RefSource>BMC Infect Dis. 2023 Jun 13;23(1):401</RefSource><PMID Version="1">37312023</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003716" MajorTopicYN="Y">Dengue Virus</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016036" MajorTopicYN="N">Seroepidemiologic Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004797" MajorTopicYN="N">Enzyme-Linked Immunosorbent Assay</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009500" MajorTopicYN="N">Neutralization Tests</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000071244" MajorTopicYN="Y">Zika Virus</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000071243" MajorTopicYN="Y">Zika Virus Infection</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007074" MajorTopicYN="N">Immunoglobulin G</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Dengue virus</Keyword><Keyword MajorTopicYN="N">ELISA</Keyword><Keyword MajorTopicYN="N">IgG-capture ELISA</Keyword><Keyword MajorTopicYN="N">Seroprevalence</Keyword></KeywordList><CoiStatement>The authors declare no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>12</Month><Day>5</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>5</Month><Day>5</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>5</Month><Day>11</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>5</Month><Day>9</Day><Hour>13</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>5</Month><Day>9</Day><Hour>10</Hour><Minute>44</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37158835</ArticleId><ArticleId IdType="pmc">PMC10165301</ArticleId><ArticleId IdType="doi">10.1186/s12879-023-08307-8</ArticleId><ArticleId IdType="pii">10.1186/s12879-023-08307-8</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Guzman MG, Harris E, Dengue. 2015;385:453&#x2013;65.</Citation><ArticleIdList><ArticleId IdType="pubmed">25230594</ArticleId></ArticleIdList></Reference><Reference><Citation>Bhatt S, Gething PW, Brady OJ, Messina JP, Farlow AW, Moyes CL, et al. The global distribution and burden of dengue. Nature. 2013;496:504&#x2013;7. doi: 10.1038/nature12060.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature12060</ArticleId><ArticleId IdType="pmc">PMC3651993</ArticleId><ArticleId IdType="pubmed">23563266</ArticleId></ArticleIdList></Reference><Reference><Citation>World Health Organization. 2009. Dengue hemorrhagic fever: Diagnosis, treatment, prevention and control. 3rd ed, Geneva, Switzerland.</Citation></Reference><Reference><Citation>Halstead SB. Pathogenesis of dengue: challenges to molecular biology. Science. 1988;239:476&#x2013;81. doi: 10.1126/science.3277268.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.3277268</ArticleId><ArticleId IdType="pubmed">3277268</ArticleId></ArticleIdList></Reference><Reference><Citation>Halstead SB, Dans LF. Dengue infection and advances in dengue vaccines for children. Lancet Child Adolesc Health. 2019;3:734&#x2013;41. doi: 10.1016/S2352-4642(19)30205-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2352-4642(19)30205-6</ArticleId><ArticleId IdType="pubmed">31378686</ArticleId></ArticleIdList></Reference><Reference><Citation>Iacobucci G. WHO recommends additional tests for Sanofi&#x2019;s dengue vaccine after safety concerns. BMJ. 2018;20:361.</Citation><ArticleIdList><ArticleId IdType="pubmed">29678901</ArticleId></ArticleIdList></Reference><Reference><Citation>World Health Organization. Dengue and severe dengue. https://www.who.int/news-room/fact-sheets/detail/dengue-and-severe-dengue.</Citation></Reference><Reference><Citation>Sridhar S, Luedtke A, Langevin E, Zhu M, Bonaparte M, Machabert T, et al. Effect of dengue serostatus on dengue vaccine safety and efficacy. N Engl J Med. 2018;379:327&#x2013;40. doi: 10.1056/NEJMoa1800820.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa1800820</ArticleId><ArticleId IdType="pubmed">29897841</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen Y, Li N, Louren&#xe7;o J, Wang L, Cazelles B, Dong L, et al. Measuring the effects of COVID-19-related disruption on dengue transmission in southeast Asia and Latin America: a statistical modelling study. Lancet Infect Dis. 2022;22:657&#x2013;67. doi: 10.1016/S1473-3099(22)00025-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(22)00025-1</ArticleId><ArticleId IdType="pmc">PMC8890758</ArticleId><ArticleId IdType="pubmed">35247320</ArticleId></ArticleIdList></Reference><Reference><Citation>Sasmono RT, Santoso MS. Movement dynamics: reduced dengue cases during the COVID-19 pandemic. Lancet Infect Dis. 2022;22:570&#x2013;1. doi: 10.1016/S1473-3099(22)00062-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(22)00062-7</ArticleId><ArticleId IdType="pmc">PMC8890753</ArticleId><ArticleId IdType="pubmed">35247322</ArticleId></ArticleIdList></Reference><Reference><Citation>Pierson TC, Diamond MS. 2013. Flaviviruses. Knipe DM, Howley PM, eds. Fields virology, 6th ed, Philadelphia: Lippincott William &amp; Wilkins. pp&#xa0;747&#x2013;794.</Citation></Reference><Reference><Citation>Tsai WY, Lin HE, Wang WK. Complexity of human antibody response to dengue virus: implication for vaccine development. Front Microbiol. 2017;8:1372. doi: 10.3389/fmicb.2017.01372.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmicb.2017.01372</ArticleId><ArticleId IdType="pmc">PMC5517401</ArticleId><ArticleId IdType="pubmed">28775720</ArticleId></ArticleIdList></Reference><Reference><Citation>Lai CY, Tsai WY, Lin SR, Kao CL, Hu SP, King CC, et al. Antibodies to envelope glycoprotein of dengue virus during the natural course of infection are predominantly cross-reactive and recognize epitopes containing highly conserved residues at the fusion loop of domain II. J Virol. 2008;82:6631&#x2013;43. doi: 10.1128/JVI.00316-08.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.00316-08</ArticleId><ArticleId IdType="pmc">PMC2447043</ArticleId><ArticleId IdType="pubmed">18448542</ArticleId></ArticleIdList></Reference><Reference><Citation>Lanciotti RS, Kosoy OL, Laven JJ, Velez JO, Lambert AJ, Johnson AJ, et al. Genetic and serologic properties of Zika virus associated with an epidemic, Yap State, Micronesia, 2007. Emerg Infect Dis. 2008;14:1232&#x2013;9. doi: 10.3201/eid1408.080287.</Citation><ArticleIdList><ArticleId IdType="doi">10.3201/eid1408.080287</ArticleId><ArticleId IdType="pmc">PMC2600394</ArticleId><ArticleId IdType="pubmed">18680646</ArticleId></ArticleIdList></Reference><Reference><Citation>Johnson BW, Kosoy O, Martin DA, Noga AJ, Russell BJ, Johnson AA, et al. West Nile virus infection and serologic response among persons previously vaccinated against yellow fever and japanese encephalitis viruses. Vector Borne Zoonotic Dis. 2005;5:137&#x2013;45. doi: 10.1089/vbz.2005.5.137.</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/vbz.2005.5.137</ArticleId><ArticleId IdType="pubmed">16011430</ArticleId></ArticleIdList></Reference><Reference><Citation>Felix AC, Souza NCS, Figueiredo WM, Costa AA, Inenami M, da Silva RMG, et al. Cross reactivity of commercial anti-dengue immunoassays in patients with acute Zika virus infection. J Med Virol. 2017;89:1477&#x2013;9. doi: 10.1002/jmv.24789.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.24789</ArticleId><ArticleId IdType="pubmed">28229481</ArticleId></ArticleIdList></Reference><Reference><Citation>van Meer MPA, M&#xf6;gling R, Klaasse J, Chandler FD, Pas SD, van der Eijk AA, et al. Re-evaluation of routine dengue virus serology in travelers in the era of Zika virus emergence. J Clin Virol. 2017;92:25&#x2013;31. doi: 10.1016/j.jcv.2017.05.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jcv.2017.05.001</ArticleId><ArticleId IdType="pubmed">28505571</ArticleId></ArticleIdList></Reference><Reference><Citation>Guidance for U.S. Laboratories Testing for Zika Virus Infection. From CDC&#x2019;s website: http://www.cdc.gov/zika/laboratories/lab-guidance.html.</Citation></Reference><Reference><Citation>Proesmans S, Katshongo F, Milambu J, Fungula B, Muhindo Mavoko H, Ahuka-Mundeke S, et al. Dengue and chikungunya among outpatients with acute undifferentiated fever in Kinshasa, Democratic Republic of Congo: a cross-sectional study. PLoS Negl Trop Dis. 2019;13:e0007047. doi: 10.1371/journal.pntd.0007047.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pntd.0007047</ArticleId><ArticleId IdType="pmc">PMC6748445</ArticleId><ArticleId IdType="pubmed">31487279</ArticleId></ArticleIdList></Reference><Reference><Citation>Elaagip A, Alsedig K, Altahir O, Ageep T, Ahmed A, Siam HA, et al. Seroprevalence and associated risk factors of dengue fever in Kassala state, eastern Sudan. PLoS Negl Trop Dis. 2020;14:e0008918. doi: 10.1371/journal.pntd.0008918.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pntd.0008918</ArticleId><ArticleId IdType="pmc">PMC7752093</ArticleId><ArticleId IdType="pubmed">33296362</ArticleId></ArticleIdList></Reference><Reference><Citation>Selvarajoo S, Liew JWK, Tan W, Lim XY, Refai WF, Zaki RA, et al. Knowledge, attitude and practice on dengue prevention and dengue seroprevalence in a dengue hotspot in Malaysia: a cross-sectional study. Sci Rep. 2020;10:9534. doi: 10.1038/s41598-020-66212-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-020-66212-5</ArticleId><ArticleId IdType="pmc">PMC7293214</ArticleId><ArticleId IdType="pubmed">32533017</ArticleId></ArticleIdList></Reference><Reference><Citation>Shah PS, Alagarasu K, Karad S, Deoshatwar A, Jadhav SM, Raut T, et al. Seroprevalence and incidence of primary dengue infections among children in a rural region of Maharashtra, Western India. BMC Infect Dis. 2019;19:296. doi: 10.1186/s12879-019-3937-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12879-019-3937-z</ArticleId><ArticleId IdType="pmc">PMC6444844</ArticleId><ArticleId IdType="pubmed">30940086</ArticleId></ArticleIdList></Reference><Reference><Citation>Dhanoa A, Hassan SS, Jahan NK, Reidpath DD, Fatt QK, Ahmad MP, et al. Seroprevalence of dengue among healthy adults in a rural community in Southern Malaysia: a pilot study. Infect Dis Poverty. 2018;7:1. doi: 10.1186/s40249-017-0384-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40249-017-0384-1</ArticleId><ArticleId IdType="pmc">PMC5769361</ArticleId><ArticleId IdType="pubmed">29335021</ArticleId></ArticleIdList></Reference><Reference><Citation>Velandia-Romero ML, Coronel-Ruiz C, Castro-Bonilla L, Camacho-Ortega S, Calder&#xf3;n-Pel&#xe1;ez MA, Castellanos A, et al. Prevalence of dengue antibodies in healthy children and adults in different colombian endemic areas. Int J Infect Dis. 2020;91:9&#x2013;16. doi: 10.1016/j.ijid.2019.10.045.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijid.2019.10.045</ArticleId><ArticleId IdType="pubmed">31733358</ArticleId></ArticleIdList></Reference><Reference><Citation>Mishra AC, Arankalle VA, Gadhave SA, Mahadik PH, Shrivastava S, Bhutkar M, et al. Stratified sero-prevalence revealed overall high disease burden of dengue but suboptimal immunity in younger age groups in Pune, India. PLoS Negl Trop Dis. 2018;12:e0006657. doi: 10.1371/journal.pntd.0006657.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pntd.0006657</ArticleId><ArticleId IdType="pmc">PMC6095695</ArticleId><ArticleId IdType="pubmed">30080850</ArticleId></ArticleIdList></Reference><Reference><Citation>Santhosh Kumar M, Kamaraj P, Khan SA, Allam RR, Barde PV, Dwibedi B, et al. Seroprevalence of dengue infection using IgG capture ELISA in India, 2017&#x2013;2018. Am J Trop Med Hyg. 2021;105:1277&#x2013;80. doi: 10.4269/ajtmh.21-0386.</Citation><ArticleIdList><ArticleId IdType="doi">10.4269/ajtmh.21-0386</ArticleId><ArticleId IdType="pmc">PMC8592208</ArticleId><ArticleId IdType="pubmed">34370710</ArticleId></ArticleIdList></Reference><Reference><Citation>Auerswald H, de Jesus A, Seixas G, Nazareth T, In S, Mao S, et al. First dengue virus seroprevalence study on Madeira Island after the 2012 outbreak indicates unreported dengue circulation. Parasit Vectors. 2019;12:103. doi: 10.1186/s13071-019-3357-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13071-019-3357-3</ArticleId><ArticleId IdType="pmc">PMC6417143</ArticleId><ArticleId IdType="pubmed">30867031</ArticleId></ArticleIdList></Reference><Reference><Citation>Gubler DJ. Dengue and dengue hemorrhagic fever. Clin Microbiol Rev. 1998;11:480&#x2013;96. doi: 10.1128/CMR.11.3.480.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/CMR.11.3.480</ArticleId><ArticleId IdType="pmc">PMC88892</ArticleId><ArticleId IdType="pubmed">9665979</ArticleId></ArticleIdList></Reference><Reference><Citation>Johnson AJ, Martin DA, Karabatsos N, Roehrig JT. Detection of anti-arboviral immunoglobulin G by using a monoclonal antibody-based capture enzyme-linked immunosorbent assay. J Clin Microbiol. 2000;38:1827&#x2013;31. doi: 10.1128/JCM.38.5.1827-1831.2000.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JCM.38.5.1827-1831.2000</ArticleId><ArticleId IdType="pmc">PMC86600</ArticleId><ArticleId IdType="pubmed">10790108</ArticleId></ArticleIdList></Reference><Reference><Citation>Martin DA, Muth DA, Brown T, Johnson AJ, Karabatsos N, Roehrig JT. Standardization of immunoglobulin M capture enzyme-linked immunosorbent assays for routine diagnosis of arboviral infections. J Clin Microbiol. 2000;38:1823&#x2013;6. doi: 10.1128/JCM.38.5.1823-1826.2000.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JCM.38.5.1823-1826.2000</ArticleId><ArticleId IdType="pmc">PMC86599</ArticleId><ArticleId IdType="pubmed">10790107</ArticleId></ArticleIdList></Reference><Reference><Citation>Vaughn DW, Nisalak A, Solomon T, Kalayanarooj S, Nguyen MD, Kneen R, et al. Rapid serologic diagnosis of dengue virus infection using a commercial capture ELISA that distinguishes primary and secondary infections. Am J Trop Med Hyg. 1999;60:693&#x2013;8. doi: 10.4269/ajtmh.1999.60.693.</Citation><ArticleIdList><ArticleId IdType="doi">10.4269/ajtmh.1999.60.693</ArticleId><ArticleId IdType="pubmed">10348250</ArticleId></ArticleIdList></Reference><Reference><Citation>Vazquez S, Hafner G, Ruiz D, Calzada N, Guzman MG. Evaluation of immunoglobulin M and G capture enzyme-linked immunosorbent assay Panbio kits for diagnostic dengue infections. J Clin Virol. 2007;39:194&#x2013;8. doi: 10.1016/j.jcv.2007.04.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jcv.2007.04.003</ArticleId><ArticleId IdType="pubmed">17521960</ArticleId></ArticleIdList></Reference><Reference><Citation>Tsai JJ, Liu CK, Tsai WY, Liu LT, Tyson J, Tsai CY, et al. Seroprevalence of dengue in two districts of Kaohsiung city after the largest dengue outbreak in Taiwan since world war II. PLoS Negl Trop Dis. 2018;12:e0006879. doi: 10.1371/journal.pntd.0006879.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pntd.0006879</ArticleId><ArticleId IdType="pmc">PMC6218099</ArticleId><ArticleId IdType="pubmed">30356316</ArticleId></ArticleIdList></Reference><Reference><Citation>Tsai WY, Chen HL, Tsai JJ, Dejnirattisai W, Jumnainsong A, Mongkolsapaya J, et al. Potent neutralizing human monoclonal antibodies preferentially target mature dengue virus particles: implication for novel strategy of dengue vaccine. J Virol. 2018;92:e00556&#x2013;18. doi: 10.1128/JVI.00556-18.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.00556-18</ArticleId><ArticleId IdType="pmc">PMC6232466</ArticleId><ArticleId IdType="pubmed">30185598</ArticleId></ArticleIdList></Reference><Reference><Citation>Tyson J, Tsai WY, Tsai JJ, Brites C, M&#xe4;ssg&#xe5;rd L, Youn HH, et al. Combination of non-structural protein 1-based enzyme-linked immunosorbent assays can detect and distinguish various dengue virus and Zika virus infections. J Clin Microbiol. 2019;57:e01464&#x2013;18. doi: 10.1128/JCM.01464-18.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JCM.01464-18</ArticleId><ArticleId IdType="pmc">PMC6355536</ArticleId><ArticleId IdType="pubmed">30429254</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang WK, Chen HL, Yang CF, Hsieh SC, Juan CC, Chang SM, et al. Slower rates of clearance of viral load and virus-containing immune complexes in patients with dengue hemorrhagic fever. Clin Infect Dis. 2006;243:1023&#x2013;30. doi: 10.1086/507635.</Citation><ArticleIdList><ArticleId IdType="doi">10.1086/507635</ArticleId><ArticleId IdType="pubmed">16983615</ArticleId></ArticleIdList></Reference><Reference><Citation>Herrera BB, Tsai WY, Brites C, Luz E, Pedroso C, Drexler JF, et al. T cell responses to nonstructural protein 3 distinguish infections by dengue and Zika viruses. mBio. 2018;9:e00755&#x2013;18.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6083909</ArticleId><ArticleId IdType="pubmed">30087165</ArticleId></ArticleIdList></Reference><Reference><Citation>Wilder-Smith A, Smith PG, Luo R, Kelly-Cirino C, Curry D, Larson H, et al. Pre-vaccination screening strategies for the use of the CYD-TDV dengue vaccine: a meeting report. Vaccine. 2019;37:5137&#x2013;46. doi: 10.1016/j.vaccine.2019.07.016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.vaccine.2019.07.016</ArticleId><ArticleId IdType="pubmed">31377079</ArticleId></ArticleIdList></Reference><Reference><Citation>Innis BL. Antibody responses to dengue virus infection. In: Gubler DJ, Kuno G, editors. Dengue and dengue hemorrhagic fever. New York: CAB International; 1997. pp. 221&#x2013;44.</Citation></Reference><Reference><Citation>Puschnik A, Lau L, Cromwell EA, Balmaseda A, Zompi S, Harris E. Correlation between dengue-specific neutralizing antibodies and serum avidity in primary and secondary dengue virus 3 natural infections in humans. PLoS Negl Trop Dis. 2913;7:e2274. doi: 10.1371/journal.pntd.0002274.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pntd.0002274</ArticleId><ArticleId IdType="pmc">PMC3681624</ArticleId><ArticleId IdType="pubmed">23785536</ArticleId></ArticleIdList></Reference><Reference><Citation>Tissera H, Amarasinghe A, De Silva AD, Kariyawasam P, Corbett KS, Katzelnick L, et al. Burden of dengue infection and disease in a pediatric cohort in urban Sri Lanka. Am J Trop Med Hyg. 2014;91:132&#x2013;7. doi: 10.4269/ajtmh.13-0540.</Citation><ArticleIdList><ArticleId IdType="doi">10.4269/ajtmh.13-0540</ArticleId><ArticleId IdType="pmc">PMC4080552</ArticleId><ArticleId IdType="pubmed">24865684</ArticleId></ArticleIdList></Reference><Reference><Citation>Lopez AL, Adams C, Ylade M, Jadi R, Daag JV, Molloy CT, et al. Determining dengue virus serostatus by indirect IgG ELISA compared with focus reduction neutralisation test in children in Cebu, Philippines: a prospective population-based study. Lancet Glob Health. 2021;9:e44&#x2013;e51. doi: 10.1016/S2214-109X(20)30392-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2214-109X(20)30392-2</ArticleId><ArticleId IdType="pmc">PMC9358663</ArticleId><ArticleId IdType="pubmed">33212030</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>